ZA200807600B - Pharmaceutical composition containing GHRP-6 capable of preventing and elimanting fibrosis and other forms of pathological deposit in tissue - Google Patents

Pharmaceutical composition containing GHRP-6 capable of preventing and elimanting fibrosis and other forms of pathological deposit in tissue

Info

Publication number
ZA200807600B
ZA200807600B ZA200807600A ZA200807600A ZA200807600B ZA 200807600 B ZA200807600 B ZA 200807600B ZA 200807600 A ZA200807600 A ZA 200807600A ZA 200807600 A ZA200807600 A ZA 200807600A ZA 200807600 B ZA200807600 B ZA 200807600B
Authority
ZA
South Africa
Prior art keywords
elimanting
fibrosis
tissue
preventing
forms
Prior art date
Application number
ZA200807600A
Other languages
English (en)
Inventor
Berlanga Acosta Jorge
Cibrian Vera Danay
Garcia Del Barco Herrera Diana
Guillen Nieto Gerardo Enrique
Suarez Alba Jose
Lopez Mola Ernesto
Selman-Housein Sosa Manuel
Vazquez Castillo Mariela
Original Assignee
Ct L De Ingenieria Genetica Y
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct L De Ingenieria Genetica Y filed Critical Ct L De Ingenieria Genetica Y
Publication of ZA200807600B publication Critical patent/ZA200807600B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF] (Somatoliberin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ZA200807600A 2006-02-28 2008-09-03 Pharmaceutical composition containing GHRP-6 capable of preventing and elimanting fibrosis and other forms of pathological deposit in tissue ZA200807600B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20060048A CU23592A1 (es) 2006-02-28 2006-02-28 Método para prevenir y eliminar las fibrosis y otras formas de depósito patológico en los tejidos aplicando el péptido secretagogo ghrp-6

Publications (1)

Publication Number Publication Date
ZA200807600B true ZA200807600B (en) 2009-06-24

Family

ID=37964643

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200807600A ZA200807600B (en) 2006-02-28 2008-09-03 Pharmaceutical composition containing GHRP-6 capable of preventing and elimanting fibrosis and other forms of pathological deposit in tissue

Country Status (16)

Country Link
US (2) US20090221512A1 (es)
EP (2) EP2368563A1 (es)
JP (1) JP5426175B2 (es)
KR (1) KR101462077B1 (es)
CN (1) CN101426517B (es)
AR (1) AR059644A1 (es)
AU (1) AU2007219568B2 (es)
BR (1) BRPI0708349B8 (es)
CA (1) CA2644431C (es)
CU (1) CU23592A1 (es)
DK (1) DK1994939T3 (es)
ES (1) ES2388879T3 (es)
MX (1) MX2008011140A (es)
RU (1) RU2465913C2 (es)
WO (1) WO2007098715A1 (es)
ZA (1) ZA200807600B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101730708B (zh) 2007-03-28 2013-09-18 哈佛大学校长及研究员协会 缝合多肽
CA2807685C (en) 2010-08-13 2020-10-06 Aileron Therapeutics, Inc. P53 derived peptidomimetic macrocycle
US9096684B2 (en) 2011-10-18 2015-08-04 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
JP6450192B2 (ja) 2012-02-15 2019-01-09 エイルロン セラピューティクス，インコーポレイテッド トリアゾール架橋した、およびチオエーテル架橋したペプチドミメティック大環状化合物
WO2013123266A1 (en) 2012-02-15 2013-08-22 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
KR101667383B1 (ko) * 2012-03-28 2016-10-18 주식회사 인코스팜 비오틴이 결합된 ｈｅｘａｐｅｐｔｉｄｅ-２ 유도체 및 이의 용도
US9604919B2 (en) 2012-11-01 2017-03-28 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
KR102051433B1 (ko) * 2013-08-27 2020-01-08 (주)네오팜 근육 분화 촉진 및 근육 강화용 조성물 및 외용제
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
AU2015320549A1 (en) 2014-09-24 2017-04-13 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
BR112017019738A2 (pt) 2015-03-20 2018-05-29 Aileron Therapeutics Inc macrociclos peptidomiméticos e usos dos mesmos
FR3034662B1 (fr) 2015-04-10 2020-08-28 Isp Investments Inc Nouvelles utilisations du peptide de sequence his-d-trp-ala-trp-d-phe-lys-nh2 pour diminuer ou retarder l'apparition de la senescence cellulaire et des signes du vieillissement cutane
RU2721284C2 (ru) * 2015-12-30 2020-05-18 Нойборон Медтех Лтд. СИСТЕМА НЕЙТРОНОЗАХВАТНОЙ ТЕРАПИИ, ПРИМЕНЯЕМАЯ ДЛЯ УДАЛЕНИЯ β-АМИЛОИДНОГО БЕЛКА
CN109908331A (zh) * 2019-04-30 2019-06-21 青岛大学附属医院 海沙瑞林在制备保护肾脏缺血再灌注损伤药物/药物组合物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411890A (en) * 1981-04-14 1983-10-25 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
EP1258250B1 (en) * 1999-12-28 2005-09-14 Kaken Pharmaceutical Co., Ltd. Nerve protective drugs
CU23157A1 (es) * 2001-01-03 2006-07-18 Ct Ingenieria Genetica Biotech COMPOSICION FARMACéUTICA PARA EL TRATAMIENTO DEL DANO TISULAR DEBIDO A FALTA DE IRRIGACION SANGUINEA ARTERIAL
JPWO2003047624A1 (ja) * 2001-12-07 2005-04-14 科研製薬株式会社 細胞遊走阻害剤
TWI331922B (en) * 2002-08-09 2010-10-21 Ipsen Pharma Sas Growth hormone releasing peptides
ES2383685T3 (es) * 2003-04-30 2012-06-25 Kenji Kangawa Preventivos o remedios para hepatopatía
JP2005239712A (ja) * 2004-01-30 2005-09-08 Kaken Pharmaceut Co Ltd 神経突起伸展剤
JP2007537434A (ja) * 2004-05-14 2007-12-20 ノボ　ノルディスク　アクティーゼルスカブ 機能的ｇｈｓ−ｒアンタゴニスト

Also Published As

Publication number Publication date
CN101426517A (zh) 2009-05-06
AU2007219568B2 (en) 2012-10-04
US20090221512A1 (en) 2009-09-03
BRPI0708349A2 (pt) 2011-05-24
US8722626B2 (en) 2014-05-13
EP1994939B1 (en) 2012-05-30
AR059644A1 (es) 2008-04-16
BRPI0708349B1 (pt) 2019-04-24
US20110230415A1 (en) 2011-09-22
JP2009528302A (ja) 2009-08-06
MX2008011140A (es) 2008-09-08
CU23592A1 (es) 2010-11-11
KR20080100378A (ko) 2008-11-17
JP5426175B2 (ja) 2014-02-26
CN101426517B (zh) 2013-04-03
EP2368563A1 (en) 2011-09-28
WO2007098715A1 (es) 2007-09-07
CA2644431A1 (en) 2007-09-07
EP1994939A1 (en) 2008-11-26
BRPI0708349B8 (pt) 2021-05-25
RU2465913C2 (ru) 2012-11-10
DK1994939T3 (da) 2012-09-10
ES2388879T3 (es) 2012-10-19
AU2007219568A1 (en) 2007-09-07
KR101462077B1 (ko) 2014-11-20
CA2644431C (en) 2016-08-30
RU2008138561A (ru) 2010-04-10

Similar Documents

Publication Publication Date Title
ZA200807600B (en) Pharmaceutical composition containing GHRP-6 capable of preventing and elimanting fibrosis and other forms of pathological deposit in tissue
HUS1900038I1 (hu) Nátrium-glükóz kotranszporter-2 inhibitorai és alkalmazási eljárásaik
IL195161A0 (en) Pharmaceutical compositions of ropinirole and methods of use thereof
IL197275A0 (en) Pharmaceutical compositions of clonazepam and methods of use thereof
IL244761A0 (en) Film-coated and/or granulated calcium-containing compounds and their use in medical preparations
EP1765379A4 (en) CO-CRISTAL PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
EP1973986A4 (en) COMPLEX BIOACTIVE COMPOSITIONS AND METHODS OF USE
IL191604A0 (en) Pharmaceutical compositions containing mixtures of polymers and active agents poorly soluble in water
EP2064550A4 (en) PRRG4 ASSOCIATED COMPOSITIONS AND METHOD FOR USE THEREOF FOR TUMOR DIAGNOSTIC PROCEDURES
IL184735A0 (en) Pharmaceutical formulations and methods of use
HK1112427A1 (en) Drug delivery compositions and related methods
GB0523576D0 (en) Drug composition and its use in therapy
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
EP1862183A4 (en) PHARMACEUTICAL COMPOSITION WITH HEAVY WATER-SOLUBLE MEDICAMENT
EP1930001A4 (en) PHARMACEUTICAL AGENT FOR THE PREVENTION AND / OR TREATMENT OF THOROTIC DISEASES
IL197273A0 (en) Pharmaceutical and sunscreen compositions comprising caspase-14
EP2051721A4 (en) PREPARATION AND PHARMACEUTICAL USE OF COMPOSITION FROM THE EXTRACT OF EUTERPE OLERACEA (ACAI)
ZA200900416B (en) Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
GB0614365D0 (en) Pharmaceutical compositions and their use
EP1970078A4 (en) COMPOSITION FOR INHIBITING A TARGET GENE IN AN EYEBORN AND REMEDY FOR ACAPIC DISEASE
EP2121596A4 (en) ATORVASTATIN STRONTIUM SALT AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
PL375008A1 (pl) Nowe zastosowanie medyczne chlorowodorku epirubicyny
IL189827A0 (en) Pharmaceutical dosage forms and compositions comprising lecoztan
ZA200609585B (en) Compositions comprising glycosaminoglycan and non steriodal anti-inflammatory drug